| 11 Earnings Per Share Basic and diluted EPS calculations are detailed as follows (in millions, except per share data):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended July 4, 2026 |
|
|
|
|
|
|
Weighted-Average Shares (1) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss per basic common share |
|
$ |
(136 |
) |
|
|
98,204 |
|
|
$ |
(1.39 |
) |
Effect of dilutive stock option, restricted stock, performance stock unit and restricted stock unit securities |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss per diluted common share |
|
$ |
(136 |
) |
|
|
98,204 |
|
|
$ |
(1.39 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
| (1) |
Includes issuance of 38,542 thousand shares of Waters common stock related to the BDS Business Acquisition. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended June 28, 2025 |
|
| |
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
Net income per basic common share |
|
$ |
147 |
|
|
|
59,515 |
|
|
$ |
2.47 |
|
Effect of dilutive stock option, restricted stock, performance stock unit
and restricted stock unit securities |
|
|
— |
|
|
|
141 |
|
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income per diluted common share |
|
$ |
147 |
|
|
|
59,656 |
|
|
$ |
2.47 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
Six Months Ended July 4, 2026 |
|
| |
|
|
|
|
Weighted-Average Shares (1) |
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
Net loss per basic common share |
|
$ |
(208 |
) |
|
|
90,041 |
|
|
$ |
(2.31 |
) |
Effect of dilutive stock option, restricted stock, performance
stock unit and restricted stock unit securities |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss per diluted common share |
|
$ |
(208 |
) |
|
|
90,041 |
|
|
$ |
(2.31 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
| (1) |
Includes issuance of 38,542 thousand shares of Waters common stock related to the BDS Business Acquisition. |
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
Six Months Ended June 28, 2025 |
|
| |
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
Net income per basic common share |
|
$ |
268 |
|
|
|
59,478 |
|
|
$ |
4.51 |
|
Effect of dilutive stock option, restricted stock, performance stock unit and restricted stock unit securities |
|
|
— |
|
|
|
208 |
|
|
|
(0.01 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income per diluted common share |
|
$ |
268 |
|
|
|
59,686 |
|
|
$ |
4.50 |
|
|
|
|
|
|
|
|
|
|
|
|
|
| The Company had 177 thousand and 234 thousand stock options that were antidilutive due to having higher exercise prices than the Company’s average stock price during the three and six months ended July 4, 2026, respectively. For the three and six months ended June 28, 2025, the Company had 92 thousand and 73 thousand stock options that were antidilutive. These securities were not included in the computation of diluted EPS. The effect of dilutive securities was calculated using the treasury stock method.
|